Founded by Dr. Chiu-Chin Huang, Shine-On Biomedical integrates medical, biotech, and R&D expertise to develop innovative drug platforms based on exosomes and multi-specific antibodies. Its R&D pipeline includes HLA-G targeted exosomes, HLA-G targeted exosomal doxorubicin, HLA-G targeted exosomal microRNA, genetically engineered stem cell-derived exosomes, nanobody-based trispecific T-cell engagers, and EphA10 trispecific immune cell engager antibodies. Through patented technologies, international CDMO and CRO partnerships, and expert consulting resources, Shine-On Biomedical advances cancer immunotherapy and next-generation biologics development with the goal of building a globally competitive new drug development platform.

Login/Register
Supplier Login

















